HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roger L Papke Selected Research

1- (5- chloro- 2- hydroxyphenyl)- 3- (2- chloro- 5- trifluoromethylphenyl)urea

1/2018Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roger L Papke Research Topics

Disease

11Inflammation (Inflammations)
01/2022 - 12/2005
9Pain (Aches)
01/2022 - 04/2015
7Tobacco Use Disorder (Nicotine Dependence)
10/2020 - 04/2007
6Alzheimer Disease (Alzheimer's Disease)
01/2021 - 04/2003
4Hyperalgesia
01/2021 - 01/2017
3Neuralgia (Stump Neuralgia)
01/2022 - 04/2015
3Chronic Pain
11/2018 - 04/2015
3Schizophrenia (Dementia Praecox)
08/2009 - 12/2005
2Neoplasms (Cancer)
10/2019 - 01/2015
2Cognitive Dysfunction
12/2018 - 08/2009
1Asthma (Bronchial Asthma)
01/2021
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2020
1Neuroinflammatory Diseases
12/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019
1Hypersensitivity (Allergy)
10/2019
1Peripheral Nervous System Diseases (PNS Diseases)
10/2019
1Edema (Dropsy)
11/2018
1Multiple Sclerosis
01/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Nervous System Diseases (Neurological Disorders)
04/2015
1Arthritis (Polyarthritis)
01/2015
1Parkinson Disease (Parkinson's Disease)
01/2015
1Experimental Arthritis
01/2015
1Substance-Related Disorders (Drug Abuse)
11/2008
1Pheochromocytoma
08/2005
1Craniocerebral Trauma (Head Injury)
04/2003
1Seizures (Absence Seizure)
04/2003
1Stroke (Strokes)
04/2003

Drug/Important Bio-Agent (IBA)

18Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2022 - 12/2005
11NicotineFDA Link
10/2020 - 04/2007
5LigandsIBA
10/2020 - 10/2012
4Formaldehyde (Formol)FDA Link
11/2018 - 04/2015
4Pharmaceutical PreparationsIBA
11/2018 - 04/2007
3Ion Channels (Ion Channel)IBA
01/2022 - 10/2012
3quinolineIBA
01/2021 - 01/2017
3LipopolysaccharidesIBA
01/2021 - 01/2017
3SulfonamidesIBA
01/2021 - 01/2017
24- (4- bromophenyl)- 3a,4,5,9b- tetrahydro- 3H- cyclopenta(c)quinoline- 8- sulfonamideIBA
01/2018 - 01/2016
21,4- diazabicyclo(3.2.2)nonan- 4- yl(5- (3- (trifluoromethyl)phenyl)furan- 2- yl)methanoneIBA
01/2018 - 04/2015
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2017 - 01/2015
23-(2,4-dimethoxybenzylidene)anabaseineIBA
08/2005 - 06/2004
1Phosphorylcholine (Phosphocholine)IBA
01/2022
1Conotoxins (Conotoxin)IBA
01/2022
1Opioid Analgesics (Opioids)IBA
01/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021
1CationsIBA
01/2021
1ChloridesIBA
01/2021
1Bumetanide (Bumex)FDA LinkGeneric
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1CalciumIBA
01/2021
1tyrosine receptor (receptor, tyrosine)IBA
01/2021
1trkB ReceptorIBA
01/2021
1epibatidineIBA
10/2020
1CytokinesIBA
01/2020
1Paclitaxel (Taxol)FDA LinkGeneric
10/2019
1Antineoplastic Agents (Antineoplastics)IBA
10/2019
1Analgesics (Analgesic Drugs)IBA
11/2018
1PNU-282987IBA
01/2018
11- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA
01/2018
11- (5- chloro- 2- hydroxyphenyl)- 3- (2- chloro- 5- trifluoromethylphenyl)ureaIBA
01/2018
1MecamylamineIBA
01/2018
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2017
1Freund's AdjuvantIBA
01/2016
1Cholinergic ReceptorsIBA
01/2016
1Acetic Acid (Vinegar)FDA LinkGeneric
04/2015
1PMP-072IBA
01/2015
1Arecoline (Arecolin)IBA
01/2015
1PMP-311IBA
01/2015
1Antipsychotic Agents (Antipsychotics)IBA
08/2009
1S 24795IBA
03/2009
1Dopamine (Intropin)FDA LinkGeneric
11/2008
11- (3- picolinium)- 12- triethylammonium- dodecane dibromideIBA
10/2007
1nornicotineIBA
04/2007
1Nerve Growth Factor (NGF)IBA
08/2005
13- (4- hydroxy- 2- methoxybenzylidene)anabaseineIBA
06/2004
1Choline (Choline Chloride)IBA
04/2003
1Phosphatidylcholines (Phosphatidylcholine)IBA
04/2003
1SolutionsIBA
04/2003

Therapy/Procedure

6Therapeutics
01/2022 - 04/2007
2Drug Therapy (Chemotherapy)
10/2019 - 11/2008